Pharmacy Times May 25, 2022

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses whether patient out of pocket costs rose in 2021, and what the implications may be for the health care system and for patients in 2022.

Pharmacy Times interviewed Murray Aitken, executive director of IQVIA Institute for Human Data Science, on the increase in spending on medicines in 2021 in the United States and implications for the US health care system.

Alana Hippensteele: Hi, I’m Alana Hippensteele with Pharmacy Times. Joining me is Murray Aitken, executive director of IQVIA Institute for Human Data Science, who is here to discuss the increase in spending on medicines in 2021 in the United States.

So how about patient out of pocket costs?...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Interview / Q&A, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Trends
CMS simplifying Medicaid, CHIP enrollment and renewal processes
Chronic care access limits diagnosis & quality for women
HIMSS24 Why Mass General Brigham Wants to Move 10% of Patient Care to the Home
The Burden of Getting Medical Care Can Exhaust Older Patients
Emergency Physicians Decry Surprise Air-Ambulance Bills

Share This Article